IL1B (Interleukin-1 beta) variants and mutations
IL1B (also known as Interleukin-1 beta) is a human protein-coding gene encoding an interleukin-1 beta protein. After inflammasome-mediated processing, it drives fever, leukocyte recruitment, and local inflammatory responses to infection or tissue damage. Excess production contributes to multiple autoinflammatory diseases and can be therapeutically suppressed by blocking IL-1 signaling. This analysis covers 546 IL1B variants and mutations. Of these, 95% have computational variant effect predictions. Disease context includes cryopyrin-associated periodic syndrome, Muckle-Wells syndrome, and gout. Example IL1B variants include E3K, V4I, and V4L.
Variant analysis overview
- Gene: IL1B
- Protein: Interleukin-1 beta
- UniProt accession: P01584
- Organism: Homo sapiens
- Variants analyzed: 546
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 275 unspecified-consequence records; 1 stop retained variant; 121 synonymous variants; 103 missense variants; 22 frameshift variants; 5 in-frame deletions; 6 stop-gained variants; 2 in-frame insertions; 6 splice-region variants; 5 substitution
- Prediction scores: 521 variants have prediction scores (95% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: cryopyrin-associated periodic syndrome, Muckle-Wells syndrome, gout, familial Mediterranean fever, juvenile idiopathic arthritis, immune system disorder, antisynthetase syndrome, pericarditis, rheumatoid arthritis, osteoarthritis, systemic-onset juvenile idiopathic arthritis, Arthritis.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable IL1B variants
Examples include E3K, V4I, V4L, P5H, P5T, A8P, A8T, A8V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- E3K (p.Glu3Lys), NCI-TCGA Cosmic COSV5452, Variant assessed as somatic; moderate impact.
- V4I (p.Val4Ile), ExAC rs755035830, TOPMed rs755035830, gnomAD rs755035830, REVEL 0.39, MetaLR 0.50
- V4L (p.Val4Leu), ExAC rs755035830, TOPMed rs755035830, gnomAD rs755035830
- P5H (p.Pro5His), NCI-TCGA TCGA novel, MetaLR 0.66, MetaSVM 0.44, Variant assessed as somatic; moderate impact.
- P5T (p.Pro5Thr), ESP rs370988408, ExAC rs370988408, TOPMed rs370988408, gnomAD rs370988408, REVEL 0.60, MetaLR 0.69
- A8P (p.Ala8Pro), ExAC rs762704392, TOPMed rs762704392, gnomAD rs762704392, REVEL 0.23, MetaLR 0.09
- A8T (p.Ala8Thr), rs762704392, NCI-TCGA Cosmic COSV5452, ExAC rs762704392, TOPMed rs762704392, REVEL 0.05, MetaLR 0.03, Variant assessed as somatic; moderate impact.
- A8V (p.Ala8Val), gnomAD rs1259285427, REVEL 0.13, MetaLR 0.08
- S9G (p.Ser9Gly), Ensembl rs1682087527, MetaLR 0.10, MetaSVM -0.98
- E10* (p.Glu10Ter), NCI-TCGA Cosmic COSV5452, Variant assessed as somatic; high impact.
- E10D (p.Glu10Asp), Ensembl rs1682087318, MetaLR 0.31, MetaSVM -0.70
- E10K (p.Glu10Lys), rs376289593, ClinGen CA1837409, ClinVar RCV001355567, 1000Genomes rs376289593, REVEL 0.31, MetaLR 0.30, Uncertain significance, not provided
- M11I (p.Met11Ile), NCI-TCGA Cosmic COSV5452, REVEL 0.17, MetaLR 0.08, Variant assessed as somatic; moderate impact.
- M11T (p.Met11Thr), ESP rs369312177, MetaLR 0.10, MetaSVM -0.99
- M11V (p.Met11Val), Ensembl rs2104937716, REVEL 0.14, MetaLR 0.05
- M12R (p.Met12Arg), ExAC rs764829099, TOPMed rs764829099, gnomAD rs764829099, REVEL 0.10, MetaLR 0.11
- M12T (p.Met12Thr), ExAC rs764829099, TOPMed rs764829099, gnomAD rs764829099, REVEL 0.05, MetaLR 0.06
- A13T (p.Ala13Thr), TOPMed rs1029215579, gnomAD rs1029215579, REVEL 0.04, MetaLR 0.11
- S16G (p.Ser16Gly), TOPMed rs1682086803, REVEL 0.20, MetaLR 0.19
- G17C (p.Gly17Cys), TOPMed rs1177805008, gnomAD rs1177805008, REVEL 0.14, MetaLR 0.19
- G17D (p.Gly17Asp), ExAC rs763810887, gnomAD rs763810887, REVEL 0.12, MetaLR 0.04
- N18T (p.Asn18Thr), gnomAD 2-112835612-T-G, REVEL 0.06, MetaLR 0.15
- E19K (p.Glu19Lys), gnomAD rs879016138, REVEL 0.19, MetaLR 0.17
- D20G (p.Asp20Gly), gnomAD rs1682073913, REVEL 0.18, MetaLR 0.14
- D20H (p.Asp20His), Ensembl rs1573279863
- D21E (p.Asp21Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D21N (p.Asp21Asn), NCI-TCGA Cosmic COSV9964, MetaLR 0.07, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- L22L (p.Leu22Leu), gnomAD 2-112835601-A-G, CADD 7.23
- F24L (p.Phe24Leu), TOPMed rs1401577973, gnomAD rs1401577973, REVEL 0.23, MetaLR 0.27
- E25K (p.Glu25Lys), NCI-TCGA Cosmic COSV9964, REVEL 0.34, MetaLR 0.34, Variant assessed as somatic; high impact.
- A26G (p.Ala26Gly), ExAC rs760315164, gnomAD rs760315164, REVEL 0.12, MetaLR 0.17
- D27G (p.Asp27Gly), Ensembl rs1682073676, REVEL 0.20, MetaLR 0.42
- D27N (p.Asp27Asn), TOPMed rs1042120804, gnomAD rs1042120804, REVEL 0.18, MetaLR 0.42
- D27D (p.Asp27Asp), rs946504736, gnomAD 2-112835584-A-G, CADD 0.33
- G28S (p.Gly28Ser), TOPMed rs1336527442, gnomAD rs1336527442, REVEL 0.14, MetaLR 0.20
- G28G (p.Gly28Gly), gnomAD 2-112835581-G-T, CADD 1.10
- P29H (p.Pro29His), gnomAD 2-112835579-G-T, REVEL 0.26, MetaLR 0.37
- P29S (p.Pro29Ser), gnomAD 2-112835580-G-A, REVEL 0.21, MetaLR 0.34
- K30Q (p.Lys30Gln), TOPMed rs1287408224, gnomAD rs1287408224, REVEL 0.04, MetaLR 0.05
- K30K (p.Lys30Lys), rs1682073427, gnomAD 2-112835575-T-C, CADD 6.53
- K30E (p.Lys30Glu), rs879016138, []
- K30T (p.Lys30Thr), rs766796135, []
- Q31E (p.Gln31Glu), gnomAD rs1419141573, REVEL 0.11, MetaLR 0.09
- Q31L (p.Gln31Leu), 1000Genomes rs200223008, ExAC rs200223008, REVEL 0.14, MetaLR 0.16, Uncertain significance
- Q31R (p.Gln31Arg), rs200223008, ClinGen CA348289575, ClinVar RCV004115704, 1000Genomes rs200223008, REVEL 0.11, MetaLR 0.16, Uncertain significance, not specified
- Q31H (p.Gln31His), gnomAD 2-112835572-C-G, REVEL 0.14, MetaLR 0.16
- Q31Q (p.Gln31Gln), rs1445888481, gnomAD 2-112835572-C-T, CADD 7.86
- M32I (p.Met32Ile), NCI-TCGA Cosmic COSV5452, MetaLR 0.11, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- M32V (p.Met32Val), gnomAD 2-112835571-T-C, REVEL 0.08, MetaLR 0.12
- K33T (p.Lys33Thr), ExAC rs766796135, TOPMed rs766796135, gnomAD rs766796135, REVEL 0.39, MetaLR 0.35
- K33M (p.Lys33Met), gnomAD 2-112835567-T-A, REVEL 0.38, MetaLR 0.36
- K33* (p.Lys33Ter), gnomAD 2-112835568-T-A, CADD 41.00
- C34* (p.Cys34Ter), NCI-TCGA Cosmic COSV5452, Variant assessed as somatic; high impact.
- C34R (p.Cys34Arg), Ensembl rs569468521, REVEL 0.13, MetaLR 0.10
- C34C (p.Cys34Cys), rs1407164744, gnomAD 2-112833573-G-A, CADD 8.44
- S35A (p.Ser35Ala), ExAC rs755758115, gnomAD rs755758115, REVEL 0.09, MetaLR 0.10
- F36C (p.Phe36Cys), TOPMed rs950247548, gnomAD rs950247548, REVEL 0.16, MetaLR 0.13
- F36V (p.Phe36Val), ESP rs373677368, ExAC rs373677368, TOPMed rs373677368, gnomAD rs373677368, REVEL 0.10, MetaLR 0.09
- Q37Q (p.Gln37Gln), rs1465902006, gnomAD 2-112833564-C-T, CADD 5.18
- D38E (p.Asp38Glu), rs918845589, ClinGen CA53699039, ClinVar RCV004119204, gnomAD rs918845589, REVEL 0.15, MetaLR 0.15, Uncertain significance, not specified
- D38V (p.Asp38Val), gnomAD 2-112833562-T-A, REVEL 0.15, MetaLR 0.19
- L39M (p.Leu39Met), TOPMed rs1273629321, gnomAD rs1273629321, REVEL 0.13, MetaLR 0.23
- L39P (p.Leu39Pro), TOPMed rs1682031629
- L39L (p.Leu39Leu), rs767111055, gnomAD 2-112833558-C-T, CADD 5.55
- L39V (p.Leu39Val), gnomAD 2-112833560-G-C, REVEL 0.04, MetaLR 0.08
- D40E (p.Asp40Glu), Ensembl rs373127037
- D40H (p.Asp40His), TOPMed rs1573278386, REVEL 0.15, MetaLR 0.26
- D40Y (p.Asp40Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D40D (p.Asp40Asp), gnomAD 2-112833555-G-A, CADD 3.02
- D40V (p.Asp40Val), gnomAD 2-112833556-T-A, REVEL 0.14, MetaLR 0.28
- D40T (p.Asp40Thr), gnomAD 2-112833556-TC-T, CADD 23.40
- L41H (p.Leu41His), gnomAD rs1280402394, REVEL 0.10, MetaLR 0.14
- L41I (p.Leu41Ile), NCI-TCGA Cosmic COSV5452, Variant assessed as somatic; moderate impact.
- L41V (p.Leu41Val), gnomAD rs1341342014
- L41L (p.Leu41Leu), gnomAD 2-112833552-G-C, CADD 4.25
- L41F (p.Leu41Phe), gnomAD 2-112833554-G-A, REVEL 0.13, MetaLR 0.17
- C42S (p.Cys42Ser), Ensembl rs369824057
- C42Y (p.Cys42Tyr), Ensembl rs1682030902, REVEL 0.13, MetaLR 0.20
- P43S (p.Pro43Ser), gnomAD rs1425569299, REVEL 0.09, MetaLR 0.03
- P43R (p.Pro43Arg), gnomAD 2-112833547-G-C, REVEL 0.13, MetaLR 0.07
- P43L (p.Pro43Leu), gnomAD 2-112833547-G-A, REVEL 0.05, MetaLR 0.06
- D45Y (p.Asp45Tyr), NCI-TCGA Cosmic COSV9964, Variant assessed as somatic; moderate impact.
- D45N (p.Asp45Asn), gnomAD 2-112833542-C-T, REVEL 0.17, MetaLR 0.15
- G46D (p.Gly46Asp), ExAC rs758962139, gnomAD rs758962139, REVEL 0.09, MetaLR 0.07
- G46G (p.Gly46Gly), rs140794289, gnomAD 2-112833537-G-A, CADD 2.96
- G47S (p.Gly47Ser), ESP rs140821206, ExAC rs140821206, TOPMed rs140821206, gnomAD rs140821206, REVEL 0.06, MetaLR 0.05
- G47G (p.Gly47Gly), rs143589371, gnomAD 2-112833534-G-A, CADD 6.94
- Q49K (p.Gln49Lys), rs529396429, ClinGen CA1837360, ClinVar RCV004077224, ExAC rs529396429, REVEL 0.09, MetaLR 0.11, Uncertain significance, not specified
- Q49Q (p.Gln49Gln), rs2104936063, gnomAD 2-112833528-C-T, CADD 5.54
- L50I (p.Leu50Ile), TOPMed rs1191166603, gnomAD rs1191166603, REVEL 0.37, MetaLR 0.38
- L50L (p.Leu50Leu), rs760831358, gnomAD 2-112833525-T-C, CADD 1.37
- R51* (p.Arg51Ter), rs1466522013, NCI-TCGA Cosmic COSV5452, gnomAD rs1466522013, CADD 33.00, Variant assessed as somatic; high impact.
- R51Q (p.Arg51Gln), rs775562734, NCI-TCGA Cosmic COSV5452, ExAC rs775562734, TOPMed rs775562734, REVEL 0.04, MetaLR 0.02, Variant assessed as somatic; moderate impact.
- I52L (p.Ile52Leu), gnomAD rs1173863937, REVEL 0.07, MetaLR 0.08
- S53Y (p.Ser53Tyr), TOPMed rs1449638481, REVEL 0.36, MetaLR 0.41
- S53S (p.Ser53Ser), rs538083388, gnomAD 2-112833516-G-A, CADD 3.20
- D54E (p.Asp54Glu), gnomAD rs1251628937, REVEL 0.06, MetaLR 0.03
- D54H (p.Asp54His), 1000Genomes rs568715066, ExAC rs568715066, TOPMed rs568715066, gnomAD rs568715066, Uncertain significance
- D54N (p.Asp54Asn), rs568715066, ClinGen CA1837356, ClinVar RCV004290543, 1000Genomes rs568715066, REVEL 0.02, MetaLR 0.05, Uncertain significance, not specified
- D54D (p.Asp54Asp), rs1251628937, gnomAD 2-112833513-G-A, CADD 0.67
- D54T (p.Asp54Thr), gnomAD 2-112833515-CG-C, CADD 16.80
- H55R (p.His55Arg), gnomAD rs1213680063, REVEL 0.05, MetaLR 0.07
- H55H (p.His55His), gnomAD 2-112833510-G-A, CADD 0.59
- H56D (p.His56Asp), TOPMed rs1200416558, gnomAD rs1200416558, REVEL 0.14, MetaLR 0.12
- H56Q (p.His56Gln), gnomAD rs1435944698, MetaLR 0.12, MetaSVM -0.98
- H56Y (p.His56Tyr), TOPMed rs1200416558, gnomAD rs1200416558, REVEL 0.09, MetaLR 0.12
- Y57N (p.Tyr57Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y57Y (p.Tyr57Tyr), rs16062, gnomAD 2-112833504-G-A, CADD 1.32
- K59E (p.Lys59Glu), gnomAD 2-112833500-T-C, REVEL 0.04, MetaLR 0.08
- G60D (p.Gly60Asp), TOPMed rs1682029615, MetaLR 0.09, MetaSVM -0.98
- G60S (p.Gly60Ser), gnomAD 2-112833497-C-T, REVEL 0.04, MetaLR 0.02
- F61F (p.Phe61Phe), rs770945985, gnomAD 2-112833492-G-A, CADD 4.62
- R62R (p.Arg62Arg), rs749096227, gnomAD 2-112833489-C-T, CADD 3.77
- R62G (p.Arg62Gly), gnomAD 2-112833491-T-C, REVEL 0.21, MetaLR 0.21
- Q63R (p.Gln63Arg), 1000Genomes rs200278471, ExAC rs200278471, TOPMed rs200278471, gnomAD rs200278471, REVEL 0.11, MetaLR 0.08
- Q63E (p.Gln63Glu), gnomAD 2-112833488-G-C, REVEL 0.12, MetaLR 0.17
- A64A (p.Ala64Ala), rs1682029410, gnomAD 2-112833483-G-A, CADD 0.15
- A64T (p.Ala64Thr), gnomAD 2-112833485-C-T, REVEL 0.07, MetaLR 0.08
- A65E (p.Ala65Glu), ESP rs371093341, ExAC rs371093341, TOPMed rs371093341, gnomAD rs371093341, REVEL 0.34, MetaLR 0.09
- A65P (p.Ala65Pro), ExAC rs755957216, TOPMed rs755957216, gnomAD rs755957216, REVEL 0.27, MetaLR 0.09
- A65T (p.Ala65Thr), rs755957216, NCI-TCGA Cosmic COSV5452, ExAC rs755957216, TOPMed rs755957216, REVEL 0.12, MetaLR 0.07, Variant assessed as somatic; moderate impact.
- A65V (p.Ala65Val), ESP rs371093341, ExAC rs371093341, TOPMed rs371093341, gnomAD rs371093341, REVEL 0.20, MetaLR 0.02
- A65A (p.Ala65Ala), rs780676196, gnomAD 2-112833480-C-T, CADD 2.52
- A65G (p.Ala65Gly), gnomAD 2-112833480-CG-C, CADD 20.50
- S66S (p.Ser66Ser), gnomAD 2-112833477-T-C, CADD 0.23
- V67L (p.Val67Leu), gnomAD rs1213010234, REVEL 0.09, MetaLR 0.04
- V68A (p.Val68Ala), TOPMed rs1275442201, gnomAD rs1275442201, REVEL 0.35, MetaLR 0.28
- V69L (p.Val69Leu), TOPMed rs1438718924, gnomAD rs1438718924, REVEL 0.26, MetaLR 0.25
- V69M (p.Val69Met), TOPMed rs1438718924, gnomAD rs1438718924, REVEL 0.30, MetaLR 0.24
- V69V (p.Val69Val), rs1682028913, gnomAD 2-112833468-C-T, CADD 1.93
- V69del (p.Val69del), gnomAD 2-112833468-CACA-, CADD 10.60
- V69A (p.Val69Ala), gnomAD 2-112833469-A-G, REVEL 0.29, MetaLR 0.27
- A70S (p.Ala70Ser), Ensembl rs1558783084, REVEL 0.28, MetaLR 0.45
- M71V (p.Met71Val), Ensembl rs1573278265, REVEL 0.05, MetaLR 0.02
- D72E (p.Asp72Glu), TOPMed rs1229772915, gnomAD rs1229772915, REVEL 0.15, MetaLR 0.01
- D72T (p.Asp72Thr), gnomAD 2-112833460-TC-T, CADD 24.40
- D72N (p.Asp72Asn), gnomAD 2-112833461-C-T, REVEL 0.13, MetaLR 0.06
- K73E (p.Lys73Glu), Ensembl rs965893181
- K73Q (p.Lys73Gln), NCI-TCGA Cosmic COSV9964, MetaLR 0.31, MetaSVM -0.38, Variant assessed as somatic; moderate impact.
- K73K (p.Lys73Lys), rs1290371666, gnomAD 2-112833456-C-T, CADD 6.55
- L74M (p.Leu74Met), Ensembl rs1682028658
- L74P (p.Leu74Pro), NCI-TCGA TCGA novel, REVEL 0.47, MetaLR 0.25, Variant assessed as somatic; moderate impact.
- L74L (p.Leu74Leu), rs754564004, gnomAD 2-112833453-C-T, CADD 6.16
- R75K (p.Arg75Lys), Ensembl rs1682028552, REVEL 0.04, MetaLR 0.03
- R75S (p.Arg75Ser), Ensembl rs1682028513
- R75R (p.Arg75Arg), gnomAD 2-112833450-C-T, CADD 6.41
- R75* (p.Arg75Ter), gnomAD 2-112833453-C-CAG, CADD 23.70
- K76N (p.Lys76Asn), ExAC rs750985322, TOPMed rs750985322, gnomAD rs750985322, MetaLR 0.06, MetaSVM -1.03
- K76R (p.Lys76Arg), TOPMed rs936240268, REVEL 0.02, MetaLR 0.07
- K76K (p.Lys76Lys), rs750985322, gnomAD 2-112833447-C-T, CADD 0.28
- M77I (p.Met77Ile), Ensembl rs1682028283, REVEL 0.06, MetaLR 0.04
- M77V (p.Met77Val), TOPMed rs1682028333, REVEL 0.04, MetaLR 0.08
- L78L (p.Leu78Leu), rs62157449, gnomAD 2-112833441-C-T, CADD 0.28
- V79I (p.Val79Ile), gnomAD 2-112833440-C-T, REVEL 0.09, MetaLR 0.09
- P80S (p.Pro80Ser), rs1402971251, ClinGen CA348288635, ClinVar RCV004310318, gnomAD rs1402971251, REVEL 0.02, MetaLR 0.06, Uncertain significance, not specified
- P80P (p.Pro80Pro), rs1174759418, gnomAD 2-112833435-G-A, CADD 3.71
- P80A (p.Pro80Ala), gnomAD 2-112833437-G-C, REVEL 0.04, MetaLR 0.08
- C81Y (p.Cys81Tyr), gnomAD 2-112833433-C-T, REVEL 0.10, MetaLR 0.08
- C81G (p.Cys81Gly), gnomAD 2-112833434-A-C, REVEL 0.15, MetaLR 0.11
- P82P (p.Pro82Pro), rs1413517154, gnomAD 2-112833429-T-A, CADD 3.94
- T84A (p.Thr84Ala), gnomAD rs1425443645, REVEL 0.11, MetaLR 0.04
- T84I (p.Thr84Ile), TOPMed rs1211756181, REVEL 0.06, MetaLR 0.06
- T84N (p.Thr84Asn), TOPMed rs1211756181
- T84S (p.Thr84Ser), TOPMed rs1211756181, MetaLR 0.05, MetaSVM -1.00
- F85C (p.Phe85Cys), ESP rs376341819, ExAC rs376341819, TOPMed rs376341819, gnomAD rs376341819, REVEL 0.29, MetaLR 0.34
- F85L (p.Phe85Leu), gnomAD 2-112833420-G-C, REVEL 0.20, MetaLR 0.12
- F85S (p.Phe85Ser), gnomAD 2-112833421-A-G, REVEL 0.29, MetaLR 0.33
- Q86Q (p.Gln86Gln), rs868749744, gnomAD 2-112833417-C-T, CADD 4.56
- E87D (p.Glu87Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E87K (p.Glu87Lys), NCI-TCGA Cosmic COSV5452, NCI-TCGA Cosmic COSV9964, Variant assessed as somatic; moderate impact.
- N88N (p.Asn88Asn), rs373172825, gnomAD 2-112833411-A-G, CADD 0.99
- D89N (p.Asp89Asn), ESP rs371339015, ExAC rs371339015, TOPMed rs371339015, gnomAD rs371339015, REVEL 0.36, MetaLR 0.36
- D89D (p.Asp89Asp), rs531916859, gnomAD 2-112833408-G-A, CADD 6.47
- D89Y (p.Asp89Tyr), gnomAD 2-112833410-C-A, REVEL 0.35, MetaLR 0.45
- L90M (p.Leu90Met), Ensembl rs1010163835, REVEL 0.18, MetaLR 0.21
- L90P (p.Leu90Pro), TOPMed rs1459050542, gnomAD rs1459050542, REVEL 0.28, MetaLR 0.19
- L90L (p.Leu90Leu), gnomAD 2-112833405-C-T, CADD 5.51
- S91R (p.Ser91Arg), gnomAD rs1240993620, REVEL 0.04, MetaLR 0.03
- S91T (p.Ser91Thr), TOPMed rs903317448, REVEL 0.06, MetaLR 0.05
- T92I (p.Thr92Ile), 1000Genomes rs200401035, ExAC rs200401035, TOPMed rs200401035, gnomAD rs200401035, REVEL 0.12, MetaLR 0.14
Public IL1B analysis runs
- IL1B analysis run — IL1B (546 variants) — completed 2026-08-19